Athira Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Athira Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About ATHA

LeonaBio, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. 

CEO
Mark J. Litton, PhD, MBA
CEOMark J. Litton, PhD, MBA
Employees
26
Employees26
Headquarters
Bothell, Washington
HeadquartersBothell, Washington
Founded
2011
Founded2011
Employees
26
Employees26

ATHA Key Statistics

Market cap
14.28M
Market cap14.28M
Price-Earnings ratio
-0.94
Price-Earnings ratio-0.94
Dividend yield
Dividend yield
Average volume
141.59K
Average volume141.59K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.21
52 Week high$14.21
52 Week low
$2.20
52 Week low$2.20

Stock Snapshot

The current Athira Pharma(ATHA) stock price is $3.62, with a market capitalization of 14.28M. The stock trades at a price-to-earnings (P/E) ratio of -0.94.

On 2026-03-26, Athira Pharma(ATHA) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 141.59K.

The stock's 52-week range extends from a low of $2.20 to a high of $14.21.

The stock's 52-week range extends from a low of $2.20 to a high of $14.21.

People also own

Based on the portfolios of people who own ATHA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.